13Phantom Perception and the Neuropathic-Pain Parallel

FTwo phantoms, one logic

A phantom percept is a conscious sensation generated by the brain in the absence of any matching external stimulus. Tinnitus — sound without sound — sits in the same category as phantom-limb pain, where an amputee feels a vivid limb that no longer exists, and as neuropathic pain, where a damaged nerve produces burning or shooting pain with no ongoing tissue injury. In all three the percept is real to the patient and the “noise” is internal.

The unifying observation is that each phantom is preceded by deafferentation — a loss of normal sensory input. The cochlea is silenced in tinnitus; the limb is removed or the nerve cut in pain. Rather than registering simple absence, the deprived central pathway reorganises and begins to fire on its own, and the brain reads that aberrant activity as a genuine sensation [1987].

TA history of the analogy

Tonndorf was among the first to argue, in 1987, that chronic tinnitus and chronic pain share a physiological basis, framing tinnitus as an “auditory pain” arising from disordered central processing rather than from a ringing ear [1987]. Møller later catalogued the clinical similarities — both can persist after the peripheral lesion heals, both are worsened by stress and attention, both respond to similar drugs and to neuromodulation, and both are notoriously resistant to peripheral fixes [2000].

De Ridder and colleagues sharpened the idea into a mechanistic model: tinnitus and pain are persisting aversive memory networks. The phantom is not merely generated — it is learned, consolidated and emotionally tagged, so that auditory or somatosensory cortex, parahippocampus and the anterior cingulate keep the percept alive long after the trigger [2011].

CShared mechanisms: deafferentation, disinhibition, sensitisation

The mechanistic overlap is striking. (1) Deafferentation removes excitatory drive and, crucially, the inhibition it normally recruited, leaving central neurons disinhibited. (2) Central sensitisation raises gain: dorsal-horn neurons in pain and dorsal-cochlear-nucleus/cortical neurons in tinnitus become hyper-responsive, fire spontaneously and burst. (3) Maladaptive cortical reorganisation follows — somatotopic remapping in S1 mirrors tonotopic remapping in A1, and in both the perceived location/pitch tracks the edge of the lesion [2011].

The same thalamocortical dysrhythmia — slow deafferented-zone rhythms abutting a halo of pathological gamma — has been described in both chronic pain and tinnitus, and a shared limbic circuit (amygdala, ACC, hippocampus) supplies the suffering in each [1999]. This is why tinnitus is increasingly described not as an ear disease but as a sensory-network disorder on the same spectrum as central pain [2016].

CWhat the analogy predicts — and what it borrows

If tinnitus and neuropathic pain truly share machinery, treatments should cross over — and they do. Neuromodulation developed for pain (repetitive TMS, transcranial direct-current stimulation, vagus-nerve stimulation) has been trialled in tinnitus to desynchronise maladaptive activity. Drugs from the pain pharmacopoeia — tricyclic antidepressants, gabapentinoids, NMDA-receptor antagonists and SNRIs — have been tried for tinnitus, with the clearest benefit in patients who also have anxiety or depression [2013]. Both conditions demand a biopsychosocial, multidimensional assessment of intensity, distress and impact rather than a single peripheral metric [2000].

TWhere the analogy breaks down

The parallel is a model, not an identity, and over-reading it misleads. Pain carries a powerful protective, nociceptive meaning and is mediated by dedicated nociceptive pathways with their own neurochemistry; tinnitus has no protective value and rides the ordinary auditory pathway. Allodynia and hyperalgesia — pain from innocuous or mildly noxious stimuli — have an imperfect auditory analogue in hyperacusis, but the mapping is loose. Crucially, the drug cross-over is partial: agents transformative in neuropathic pain are, at best, modestly and inconsistently effective in tinnitus, and no pharmacotherapy is yet approved for it [2013]. The analogy is best used to generate hypotheses and to explain the disorder to patients — not as a guarantee that a pain remedy will silence a phantom sound [2011].